Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04574518 · ClinicalTrials.gov registry record · NA
Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules
A NA study of Tobacco Use and Multiple Pulmonary Nodules, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 223
- Enrollment target
- 3
- Study locations
NCT04574518: Active NA study of Tobacco Use and Multiple Pulmonary Nodules, sponsored by VA Office of Research and Development.
NCT04574518 is a NA study of Tobacco Use and Multiple Pulmonary Nodules that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 223 participants, below the 376-participant average among 76 other Tobacco Use trials with a reported enrollment target (41% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04574518, a NA study of Tobacco Use and Multiple Pulmonary Nodules, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 223 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to evaluate the effectiveness of a smoking cessation outreach intervention (TeaM OUT) on increasing use of smoking cessation resources in Veterans. The hypotheses are 1) patients included in the TeaM OUT group will have higher accession of cessation services, such as counseling and medication therapies, compared to patients in enhanced usual care and 2) more patients in the TeaM OUT group will have quit smoking at one year after the intervention. Veterans with a recently diagnosed lung nodule who currently smoke will receive the TeaM OUT intervention or Enhanced Usual Care. The TeaM OUT intervention has 2 parts: 1) a letter that a) describes the nodule and the importance of cessation related to the pulmonary nodule (i.e. teachable moment) and b) notification that a Proactive IVR Quit Line will initiate contact and 2) call(s) from the Proactive IVR Quit Line which a) offers smoking cessation resources and b) helps connect the patient to those resources. The enhanced usual care group will receive a letter that provides information about how to contact the IVR Quit Line. The IVR system will track referrals to cessation services. Additional information about smoking status and use of cessation resources will be collected from the electronic health record and surveys. .
Primary Outcome
A positive (yes) response is a completed call to a patient who then indicates (by pressing the number keypad) to be connected to one or more smoking cessation resources. In the control group, if the patient calls the Optional IVR Quitline and then requests to be connected to smoking cessation resources it is counted as a positive response. Each patient will be categorized as a "yes" after her/his first positive response to the system, regardless of how many times he/she actually engages with the
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL TeaM OUT Intervention
Study Locations (3)
Minnesota
- Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis
Oregon
- VA Portland Health Care System, Portland, OR - Portland
South Carolina
- Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2022-08-12 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What the registry record for NCT04574518 still lists
NCT04574518 is an interventional study that assigns participants to a tested intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 76 other Tobacco Use trials with a reported enrollment target (41% lower).
The record links to 3 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT04574518 reports a single indexed study location in Minnesota, Oregon, South Carolina.
Frequently Asked Questions
What is clinical trial NCT04574518 about?
NCT04574518 is a clinical study titled "Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules". The purpose of this study is to evaluate the effectiveness of a smoking cessation outreach intervention (TeaM OUT) on increasing use of smoking cessation resources in Veterans. The hypotheses are 1) patients included in the TeaM OUT group will have higher accession of cessation services, such as cou...
What is the current status of trial NCT04574518?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 223 participants. The study started on 2022-08-12. Estimated completion is 2026-03-31.
What conditions does trial NCT04574518 study?
This clinical trial studies the following conditions: Tobacco Use, Multiple Pulmonary Nodules, Solitary Pulmonary Nodule.
What interventions are being tested in trial NCT04574518?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), TeaM OUT Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04574518?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04574518 being conducted?
This trial has 3 study locations across Minnesota, Oregon, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04574518's enrollment target sits among peer trials
223 24th of 76 higher than 53 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06640803 · 223 participants · NA
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
- NCT07175285 · 223 participants
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- NCT07205718 · 223 participants · Phase 1
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI